Rapport Therapeutics Inc (RAPP)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Mar 2024 | Jun 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -17.09M | -20.8M |
| Pre Tax Income | -22.67M | -18.12M |
| Net Income | -22.67M | -18.12M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 |
| EBIT | -17.09M | -28.19M |
| EBITDA | -16.94M | -20.59M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -10.37M | -36.18M |
| Pre Tax Income | -10.65M | -34.78M |
| Net Income | -10.65M | -34.79M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.15 | -0.186 |
| EBIT | -10.37M | -36.18M |
| EBITDA | -10.35M | -36.07M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
